Quality of life with biweekly docetaxel and capecitabine in advanced gastro-oesophageal cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1433-7339
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Quality of life with biweekly docetaxel and capecitabine in advanced gastro-oesophageal cancer ; day:20 ; month:4 ; year:2017 ; pages:1-7
Supportive care in cancer ; (20.4.2017), 1-7
- Keyword
-
Krebs
Onkologie
- Creator
-
Korkeila, E. A.
- Contributor
-
Salminen, T.
Kallio, R.
Mikkola, M.
Auvinen, P.
Pyrhönen, S.
Ristamäki, R.
SpringerLink (Online service)
- DOI
-
10.1007/s00520-017-3689-5
- URN
-
urn:nbn:de:1111-201705046286
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Korkeila, E. A.
- Salminen, T.
- Kallio, R.
- Mikkola, M.
- Auvinen, P.
- Pyrhönen, S.
- Ristamäki, R.
- SpringerLink (Online service)
Other Objects (12)
Total neoadjuvant therapy in oesophageal and gastro-oesophageal junctional adenocarcinoma
Initial experience in staging primary oesophageal/gastro-oesophageal cancer with 18F-FDG PET/MRI
Integrative immune transcriptomic classification improves patient selection for precision immunotherapy in advanced gastro-oesophageal adenocarcinoma
Phase II study of TP300 in patients with advanced gastric or gastro-oesophageal junction adenocarcinoma
Mucosal neuroimmune mechanisms in gastro-oesophageal reflux disease (GORD) pathogenesis
Development of an implant to treat gastro-oesophageal reflux disease
Emerging aspects of oesophageal and gastro-oesophageal junction cancer histopathology – an update for the surgical oncologist
Impact of gastro-oesophageal reflux on microRNA expression, location and function
Neoadjuvant docetaxel and capecitabine (TX) versus docetaxel and epirubicin (TE) for locally advanced or early her2-negative breast cancer: an open-label, randomized, multi-center, phase II Trial
Endoscopic Removal of an Angelchik Prosthesis after Migration through the Gastro-Oesophageal Junction
The impact of operative approach on outcome of surgery for gastro-oesophageal tumours
The prevalence of dental erosion in Nigerian patients with gastro-oesophageal reflux disease
Total neoadjuvant therapy in oesophageal and gastro-oesophageal junctional adenocarcinoma
Initial experience in staging primary oesophageal/gastro-oesophageal cancer with 18F-FDG PET/MRI
Integrative immune transcriptomic classification improves patient selection for precision immunotherapy in advanced gastro-oesophageal adenocarcinoma
Phase II study of TP300 in patients with advanced gastric or gastro-oesophageal junction adenocarcinoma
Mucosal neuroimmune mechanisms in gastro-oesophageal reflux disease (GORD) pathogenesis
Development of an implant to treat gastro-oesophageal reflux disease
Emerging aspects of oesophageal and gastro-oesophageal junction cancer histopathology – an update for the surgical oncologist
Impact of gastro-oesophageal reflux on microRNA expression, location and function
Neoadjuvant docetaxel and capecitabine (TX) versus docetaxel and epirubicin (TE) for locally advanced or early her2-negative breast cancer: an open-label, randomized, multi-center, phase II Trial
Endoscopic Removal of an Angelchik Prosthesis after Migration through the Gastro-Oesophageal Junction
The impact of operative approach on outcome of surgery for gastro-oesophageal tumours
The prevalence of dental erosion in Nigerian patients with gastro-oesophageal reflux disease
Total neoadjuvant therapy in oesophageal and gastro-oesophageal junctional adenocarcinoma
Initial experience in staging primary oesophageal/gastro-oesophageal cancer with 18F-FDG PET/MRI
Integrative immune transcriptomic classification improves patient selection for precision immunotherapy in advanced gastro-oesophageal adenocarcinoma
Phase II study of TP300 in patients with advanced gastric or gastro-oesophageal junction adenocarcinoma
Mucosal neuroimmune mechanisms in gastro-oesophageal reflux disease (GORD) pathogenesis
Development of an implant to treat gastro-oesophageal reflux disease
Emerging aspects of oesophageal and gastro-oesophageal junction cancer histopathology – an update for the surgical oncologist
Impact of gastro-oesophageal reflux on microRNA expression, location and function
Neoadjuvant docetaxel and capecitabine (TX) versus docetaxel and epirubicin (TE) for locally advanced or early her2-negative breast cancer: an open-label, randomized, multi-center, phase II Trial
Endoscopic Removal of an Angelchik Prosthesis after Migration through the Gastro-Oesophageal Junction
The impact of operative approach on outcome of surgery for gastro-oesophageal tumours